Glucose and insulin are needed for optimal defensin expression in human cell lines

被引:42
作者
Barnea, Maayan [1 ]
Madar, Zecharia [1 ]
Froy, Oren [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel
关键词
defensins; hBD-1; insulin; glucose; SGLT1;
D O I
10.1016/j.bbrc.2007.12.158
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many infections are associated with diabetes, as the ability of the body to fight pathogens is impaired. Recently, low levels of defensins have been found in diabetic rodents. However, whether hyperglycemia and/or insulin deficiency/insensitivity is the reason for the reduced defensin levels is still unknown. To study the functionality of the innate immune system during hyperglycemia, the expression levels of human beta-defensin-1 (hBD-1) was measured in human embryonic kidney (HEK-293) and colon adenocarcinoma (HCT-116) cells treated with different concentrations of glucose and insulin. Increasing concentrations of glucose enhanced hBD-1 expression and these levels were further elevated after insulin treatment. Insulin treatment also led to the up-regulation of human sodium/glucose transporter 1 (hSGLT1), which further increases intracellular glucose levels. Thus, our findings suggest for the first time that insulin signaling is important for hBD-1 optimal expression by elevating intracellular glucose levels and by mediating gene expression. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:452 / 456
页数:5
相关论文
共 27 条
[1]   Human β-defensins and toll-like receptors in the upper airway [J].
Claeys, S ;
de Belder, T ;
Holtappels, G ;
Gevaert, P ;
Verhasselt, B ;
van Cauwenberge, P ;
Bachert, C .
ALLERGY, 2003, 58 (08) :748-753
[2]   Crohn's disease: a defensin deficiency syndrome? [J].
Fellermann, K ;
Wehkamp, J ;
Herrlinger, KR ;
Stange, EF .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (06) :627-634
[3]   Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways [J].
Froy, O .
CELLULAR MICROBIOLOGY, 2005, 7 (10) :1387-1397
[4]   Mouse intestinal cryptdins exhibit circadian oscillation [J].
Froy, O ;
Chapnik, N ;
Miskin, R .
FASEB JOURNAL, 2005, 19 (10) :1920-+
[5]   Differential effect of insulin treatment on decreased levels of beta-defensins and Toll-like receptors in diabetic rats [J].
Froy, Oren ;
Hananel, Amit ;
Chapnik, Nava ;
Madar, Zecharia .
MOLECULAR IMMUNOLOGY, 2007, 44 (05) :796-802
[6]   Defensins: Antimicrobial peptides of innate immunity [J].
Ganz, T .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (09) :710-720
[7]   Human β-defensin 4:: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity [J].
García, JRC ;
Krause, A ;
Schulz, S ;
Rodríguez-Jiménez, FJ ;
Klüver, E ;
Adermann, K ;
Forssmann, U ;
Frimpong-Boateng, A ;
Bals, R ;
Forssmann, WG .
FASEB JOURNAL, 2001, 15 (08) :1819-+
[8]   Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity -: Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction [J].
García, JRC ;
Jaumann, F ;
Schulz, S ;
Krause, A ;
Rodríguez-Jiménez, J ;
Forssmann, U ;
Adermann, K ;
Klüver, E ;
Vogelmeier, C ;
Becker, D ;
Hedrich, R ;
Forssmann, WG ;
Bals, R .
CELL AND TISSUE RESEARCH, 2001, 306 (02) :257-264
[9]   Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic [J].
Harder, J ;
Bartels, J ;
Christophers, E ;
Schröder, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) :5707-5713
[10]   A peptide antibiotic from human skin [J].
Harder, J ;
Bartels, J ;
Christophers, E ;
Schroder, JM .
NATURE, 1997, 387 (6636) :861-861